コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ted with lower levels of control compared to formula feeding.
2 ption for women who cannot sustain exclusive formula feeding.
3 term infants in relation to breastfeeding or formula feeding.
4 r day within their first 72 h, regardless of formula feeding.
5 ergic inflammation and infection relative to formula feeding.
6 mparisons of the effects of breastfeeding vs formula feeding.
9 domized clinical trial of breast-feeding and formula feeding among HIV-1-seropositive mothers in Nair
10 ed by Cesarean section and were subjected to formula feeding and cold asphyxia stress or were deliver
11 lly decreases in mother-fed but increases in formula feeding and cold asphyxia stress, correlating wi
12 e did not observe an association between soy formula feeding and fibroid prevalence [adjusted prevale
19 ch as direct and indirect breastfeeding, and formula feeding, and their combinations may play a role
20 y, during the period of human milk or infant formula feeding, and through introduction of complementa
21 : Control (n = 33); NEC (n = 32)-hypoxia and formula feeding; and NEC-NAC (n = 34)-received NAC (300
22 n settings with >10% community prevalence of formula feeding as compared to settings with <10% preval
26 those who were breastfed without concurrent formula feeding did not have significantly lower fat mas
27 1) although preference for breast-feeding or formula feeding does not reduce FA risk, there are dispa
30 nd exposed to the NEC protocol consisting of formula feeding (Esbilac; 200 cal.kg(-1).day(-1)) and as
33 ywhere (PROMISE) 1077 breastfeeding (BF) and formula feeding (FF) international multisite trials prov
34 fects of nutrition (breast-feeding [BRF] vs. formula-feeding [FOF]) on weight partitioning and endocr
38 ges, and higher rates of Caesarean birth and formula feeding have altered intestinal bacterial commun
42 lation and call into question the claim that formula feeding impairs infants' abilities to self regul
43 the hypothesis that high nutrient intake or formula feeding in infancy programs greater leptin conce
44 the effect of reduced colostrum intake from formula feeding in PCF infants, we analysed the associat
45 dovudine prophylaxis was not as effective as formula feeding in preventing postnatal HIV transmission
47 t for increased fibroid risk with infant soy formula feeding in women, but both cohorts relied on sel
48 ht or obesity, smoking during pregnancy, and formula-feeding in the first 6 months of life were each
52 ilk has relegated EBF to an option only when formula feeding is not affordable, feasible, safe, and s
54 0.43%) in breast-feeding mothers but not in formula-feeding mothers or nonpregnant, nonlactating wom
55 nvestigated in 47 breast-feeding mothers, 11 formula-feeding mothers, and 22 nonpregnant, nonlactatin
56 lusive breastfeeding (n = 101) and exclusive formula feeding (n = 101) at age 6 weeks and 6 months by
57 tpartum women who were lactating (n = 12) or formula-feeding (n = 6) their infants and who were close
58 plementation of 40 mg/kg/d or breast milk or formula feeding of at least 0.4% of total fatty acids, a
60 ons in HIV transmission achieved with either formula feeding or early weaning are counterbalanced by
63 t zidovudine (breastfed plus zidovudine), or formula feeding plus 1 month of infant zidovudine (formu
64 1% cow's milk allergy incidence and similar formula feeding rates between infants with and without m
66 e similar to those associated with exclusive formula feeding than exclusive breastfeeding (P = .002).
69 e feeding mode shifts from breast-feeding to formula feeding to weaning to the introduction of solid
70 t), smoking during pregnancy (vs never), and formula-feeding (vs breastfeeding) in the first 6 months